First biosimilar medicine to treat Breast Cancer
December 21 , 2019
1803 days
1111
- World Health Organization launched its first biosimilar medicine “Trastuzumab” to treat breast cancer.
- It was included in the WHO Essential Medicines List in 2015.
- The WHO intends to make the expensive, life-saving treatment affordable for women all over the world.
Post Views:
1111